{'fraction_non_alphanumeric': 0.03754266211604096, 'fraction_numerical': 0.0008532423208191126, 'mean_word_length': 5.702857142857143, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Lipid-like Diblock Copolymer as an Additive for Improving the Blood Compatibility of Poly(lactide-co-glycolide)

To optimize the blood biocompatibility of poly(lactide-coglycolide) (PLGA), lipid-like diblock copolymer poly(DL-lactide)-blockpoly(2-methacryloyloxyethyl phosphorylcholine) (PLA-b-PMPC) was employed as a surface-modifying additive. The blends of PLGA and PLA-b-PMPC coated poly(ethylene terephthalate) membranes were prepared by dip-coating. ATRFTIR spectroscopy showed the incorporation of phosphorylcoline groups in the blends and contact angle results indicated that the hydrophilicity of the blends improved with increasing PLA-b-PMPC content. The plasma recalcification time of polymer coating was prolonged and the amount of adherent platelets on coating surface was decreased by introducing PLA-b-PMPC. The adhesion of polymer coating on the gold electrode of quartz crystal microbalance was monitored and PLGA containing PLA-b-PMPC additives showed excellent polymer–metal adhesion. These results show that the blends of PLGA and lipidlike PLA-b-PMPC could be used as high performance biodegradable polymer coatings for blood contact medical devices.